Disease/Infection News

RSS

New drug launches for HCV in the Philippines to increase market earned revenues to $4.5 billion by 2017

Efforts to raise disease awareness in the Philippines have increased the number of cases and patient pool available for hepatitis C treatment. Screening and detection efforts by the Red Cross as well as growing awareness in the Philippines have been largely responsible for the rise in the number of diagnosed cases. These campaigns have encouraged people, mostly from the urban areas, to opt for physical examinations that enable the detection of hepatitis C.

15 Jul 2010

First 1M doses of smallpox vaccine for immune-compromised populations delivered

Delivery to the Strategic National Stockpile of the first 1 million doses of the nation's first smallpox vaccine for certain immune-compromised populations is now complete, the result of a Project BioShield contract.

15 Jul 2010

UNC research to be presented at International AIDS Society conference

Dozens of UNC researchers are heading to Vienna, Austria to participate in the world's preeminent AIDS conference this week. The International AIDS Society conference brings together top scientists, advocates and government officials to discuss progress and chart a course for stemming the spread and impact of AIDS. Speakers including President Bill Clinton will address an estimated 25,000 attendees at this year's event.

15 Jul 2010

Over half of UK swine flu hospital admissions, deaths occurred in previously healthy people: Research

Over half of UK swine flu hospital admissions and inpatient deaths occurred in people with no underlying health problems or obvious risk factors, research at the University of Liverpool has found.

15 Jul 2010

Pennsylvanians should take steps to reduce exposure to mosquitoes, Secretary of Health advises

The Pennsylvania Department of Health reminds Pennsylvanians to take precautions to reduce exposure to mosquitoes as the season arrives for West Nile virus, or WNV, infections.

15 Jul 2010

AVAC Report surveys state of biomedical HIV prevention research

A new report from AVAC surveys the state of biomedical HIV prevention research, including the first evidence of vaccine-induced protection in humans and the emergence of ARV-based prevention -- and provides strategic recommendations for moving forward in a time of constrained resources and faltering commitment to ending AIDS.

15 Jul 2010

New HIV treatment strategy could reduce HIV-related deaths by 10M in 15 years, UNAIDS says

UNAIDS on Tuesday outlined a new strategy, called "Treatment 2.0," to simplify the provision of HIV treatment and improve global access to antiretrovirals, Reuters reports. The agency says the plan could prevent up to 10 million AIDS-related deaths by 2025 and reduce the number of new HIV infections annually by up to one million, if all people in need receive treatment, according to the news service.

15 Jul 2010

AP further examines how PEPFAR helped inform new U.S. domestic HIV/AIDS strategy

"The national strategy for combatting HIV and AIDS the Obama administration released Tuesday credits the Bush-era international campaign against AIDS for setting clear targets and ensuring a variety of agencies and groups worked together smoothly to achieve them," the Associated Press writes in a piece that examines how PEPFAR served to inform the national strategy.

15 Jul 2010

Hendra virus treatment to be ready in a few months

Of the dozen people who were exposed to a horse infected with the Hendra virus, 11 have been cleared of the infection by repeated tests on Queensland's Sunshine Coast. These 12 people had first come into contact with the infected horse at Tewantin in May and have since then been subjected to testing to rule out infection with the deadly virus. It is expected that the 12th person will also be cleared soon. Quarantine restrictions were also lifted last month.

14 Jul 2010

NIAID awards ATCC multimillion dollar MID-BRR contract

ATCC, the premier biological materials resource, services, and standards organization, has been awarded the National Institute of Allergy and Infectious Diseases, Microbiology and Infectious Diseases Biological Resource Repository ("MID-BRR") contract, ATCC announced today. The current value of the contract is $14,615,598 with the ultimate value of $115,733,409 over 7 years with an annual renewal.

14 Jul 2010

First Edition: July 14, 2010

Today's headlines reflect coverage of new federal rules related to "meaningful use" of electronic health records as well as the latest on the federal deficit, the White House's new HIV/AIDS strategy and other developments.

14 Jul 2010

Health Canada approves FluMist for preventing seasonal influenza

AstraZeneca Canada Inc. announced today that Health Canada has approved FluMist (Influenza Vaccine, Live, Attenuated) for the prevention of seasonal influenza. FluMist is the first vaccine in Canada that is administered as a gentle mist sprayed into the nose.

14 Jul 2010

Study of relationship characteristics, motivations behind agreements among gay male couples

A new study examining the relationship dynamics of gay male couples finds that couples make "sexual agreements" -- rules about whether sex with outside partners is allowed -- primarily because they want to strengthen and improve their relationship rather than for protection against HIV. Published today in the journal AIDS Care, the study explores how sexual agreements affect both HIV risk and a relationship's satisfaction and quality, and contains insights for HIV prevention.

14 Jul 2010

White House introduces comprehensive action plan for the U.S. response to HIV/AIDS

Today, the White House introduced a comprehensive action plan for the U.S. response to HIV/AIDS. The landmark plan will serve as a roadmap for policymakers, community organizations, and the public on how to reduce new HIV infections, get people living with HIV into care, and decrease HIV-related health disparities in the United States.

14 Jul 2010

Presidio Pharmaceuticals completes Phase 1a clinical trial of PPI-461 in healthy subjects

Presidio Pharmaceuticals, Inc. announced today the successful completion of a Phase 1a clinical trial of PPI-461, its lead HCV NS5A inhibitor, in healthy subjects. This first-in-human trial evaluated four single doses of PPI-461, followed by a five-day, once-a-day treatment regimen with PPI-461 at the highest tested dose.

14 Jul 2010

Report urges multi-disciplinary research approach to help HIV-positive women stay healthy

A report issued by the Program on International Health and Human Rights at the Harvard School of Public Health proposes a new research agenda to address the sexual and reproductive health and rights of HIV-positive women.

14 Jul 2010

Pelosi applauds Obama Administration's release of National HIV/AIDS Strategy

The National HIV/AIDS Strategy represents the nation's first comprehensive plan to reduce the impact of HIV/AIDS in this country. The strategy sets specific targets and provides detailed implementation information on the steps we must take to increase access to high quality HIV/AIDS care and treatment, decrease new HIV infections, and reduce HIV-related health disparities.

14 Jul 2010

Scientists discover three human antibodies that neutralize HIV

Scientists have discovered three previously unknown human antibodies that neutralize HIV, two of which target a broad range of HIV strains. The findings, reported online July 8 in two Science papers, add a level of encouragement to the AIDS vaccine research field.

14 Jul 2010

Eban-based HIV/STD risk-reduction intervention improves safe-sex habits among high-risk African-American couples

A new study has found that heterosexual African American couples in which only one partner is HIV-positive practiced safer sexual behaviors after participating in a culturally specific intervention program designed to reduce the risk of HIV and other sexually transmitted diseases.

14 Jul 2010

IAS announces recipients of CNIHR grants

The International AIDS Society today announced the recipients of its first joint research grant programme, Creative and Novel Ideas in HIV Research. CNIHR grants, funded in partnership with the U.S. National Institutes of Health and the NIH-supported Centers for AIDS Research are designed to promote innovative research and new ideas from early stage investigators whose primary focus has previously been in fields of scientific inquiry other than HIV/ AIDS.

14 Jul 2010

Disease/Infection News

New drug launches for HCV in the Philippines to increase market earned revenues to $4.5 billion by 2017

First 1M doses of smallpox vaccine for immune-compromised populations delivered

UNC research to be presented at International AIDS Society conference

Over half of UK swine flu hospital admissions, deaths occurred in previously healthy people: Research

Pennsylvanians should take steps to reduce exposure to mosquitoes, Secretary of Health advises

AVAC Report surveys state of biomedical HIV prevention research

New HIV treatment strategy could reduce HIV-related deaths by 10M in 15 years, UNAIDS says

AP further examines how PEPFAR helped inform new U.S. domestic HIV/AIDS strategy

Hendra virus treatment to be ready in a few months

NIAID awards ATCC multimillion dollar MID-BRR contract

First Edition: July 14, 2010

Health Canada approves FluMist for preventing seasonal influenza

Study of relationship characteristics, motivations behind agreements among gay male couples

White House introduces comprehensive action plan for the U.S. response to HIV/AIDS

Presidio Pharmaceuticals completes Phase 1a clinical trial of PPI-461 in healthy subjects

Report urges multi-disciplinary research approach to help HIV-positive women stay healthy

Pelosi applauds Obama Administration's release of National HIV/AIDS Strategy

Scientists discover three human antibodies that neutralize HIV

Eban-based HIV/STD risk-reduction intervention improves safe-sex habits among high-risk African-American couples

IAS announces recipients of CNIHR grants

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News